We are live on ! Find out more
SP

Solel Partners Portfolio holdings

AUM $468M
1-Year Est. Return 2.45%
This Fund
S&P 500
This Quarter Est. Return
-12.72%
1 Year Est. Return
+2.45%
3 Year Est. Return
+16.25%
5 Year Est. Return
+25.79%
10 Year Est. Return
AUM
$543M
AUM Growth
+$80.1M
Cap. Flow
+$155M
Cap. Flow %
28.6%
Top 10 Hldgs %
67.64%
Holding
33
New
9
Increased
8
Reduced
2
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 22.58%
2 Healthcare 18.72%
3 Consumer Discretionary 12.03%
4 Materials 11.57%
5 Financials 10.58%

Similar funds

Solel Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Solel Partners held 33 positions worth $543M, up 17% from $463M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Solel Partners deployed $155M of net new capital in Q2 2022, opening 9 new positions and adding to 8 existing holdings. Its largest new stake was Bioceres Crop Solutions: 4,579,364 shares worth $62.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Universal Health Services, an estimated $21.3M trimmed.

  • Solel Partners's largest Q2 2022 buy was Bioceres Crop Solutions: 4,579,364 shares worth $62.8M.
  • Solel Partners added most to Herbalife in Q2 2022, an estimated $30M increase.
  • Solel Partners's biggest Q2 2022 reduction was Universal Health Services, cutting an estimated $21.3M.
  • Solel Partners fully exited Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant in Q2 2022, selling an estimated $10.9M.
  • Solel Partners's ten largest holdings make up 68% of its $543M portfolio in Q2 2022.
  • Solel Partners opened 9 new positions and closed 1 in Q2 2022.
  • Solel Partners's portfolio value rose 17% quarter-over-quarter to $543M.

Based on Solel Partners's 13F filing for Q2 2022, filed 15 Aug 2022.